What Are Analysts Report About CytRx Corporation (CYTR)

Money city

CytRx Corporation (CYTR) will report its next earnings on Jun 14 BMO. The company reported the earnings of $-0.06/Share in the last quarter where the estimated EPS by analysts was $-0.11/share. The difference between the expected and actual EPS was $0.05/share, which represents an Earnings surprise of 45.5%.

Some buy side analysts are also providing their Analysis on CytRx Corporation, where 0 analysts have rated the stock as Strong buy, 1 analyst have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

CytRx Corporation closed its last trading session at $0.46 with the gain of 1.28%. The Market Capitalization of the company stands at 68.09 Million. The Company has 52-week high of $3.28 and 52-week low of $0.36. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -14.98% where SMA50 and SMA200 are -1.87% and -6.18% respectively. The Company Touched its 52-Week High on 05/31/16 and 52-Week Low on 12/28/16.

The Relative Volume of the company is 1.4 and Average Volume (3 months) is 4.02 million. CytRx Corporation P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -77.9%. The Return on Equity (ROE) value stands at -199.9%. While it’s Return on Investment (ROI) value is -114.4%.

While looking at the Stock’s Performance, CytRx Corporation currently shows a Weekly Performance of -6.82%, where Monthly Performance is 5.89%, Quarterly performance is 16.47%, 6 Months performance is 3.53% and yearly performance percentage is -83.36%. Year to Date performance value (YTD perf) value is 25.92%. The Stock currently has a Weekly Volatility of 8.34% and Monthly Volatility of 12.94%.